Dow Development Laboratories
Dow Development Laboratories’ core expertise is in the development, manufacture, and testing of topical dermatological drug products for clinical use. Products are designed to be iseasecompatible, cosmetically elegant and physically and chemically stable. Our formulation, analytical, production, quality, and clinical labeling teams have decades of experience moving products quickly toward regulatory approval. DDL works seamlessly with its parent company Symbio Proinnovera, a global CRO with decades of success in conducting clinical trials, to rapidly advance dermatological programs through all stages of clinical development.
